Regard Raises $61M Series B at $350M Valuation to Enhance AI-Powered Clinical Insights

Jul 11, 2024, 02:37 PM

Regard, an AI-powered clinical insights platform, has raised $61 million in Series B funding. The round was led by Oak HC/FT and valued the company at $350 million. The investment will be used to accelerate product development, drive fundamental research in large language models (LLMs), and expand beyond inpatient facilities. Partners in this funding round include Cedars-Sinai, TenOne10, Calibrate VC, and Techstars. This funding aims to help physicians save time by analyzing patients' health data, close the clinical insights gap, and ultimately boost hospital revenue. Merck Global Health Innovation Fund announced a strategic investment to boost healthcare AI innovation.